Nutrient & Targeted Support
- Rooted in internal therapeutic interventions
- Nutrition, supplementation & evidence-informed careEVIDENCE-BASED
- Optional dermal integration where clinically relevantINTEGRATION
Testing & Strategy
- Integrative clinical approach
- Functional & pathology testing (e.g. GI Map, hormone panel)
- Detailed result interpretation
- Nutrition & supplement planning
Protocol Design
- Personalised treatment protocols
- Optional integration of dermal therapies
- Defined 3–6 week programTIMEFRAME
Case-Specific Interventions
Therapeutic Packages (Short Term, Goal-Focused)
This tier offers a high-touch, evidence-informed experience designed to resolve the underlying drivers of your concern, with structured support over a defined care window.
Whats Included
Protocol Design
- Personalised treatment protocols
- Optional integration of dermal therapies
- Defined 3-6 week program TIMEFRAME
Testing & Strategy
- Integrative clinical approach
- Functional & pathology testing (e.g. GI Map, hormone panel)
- Detailed result interpretation
- Nutrition & supplement planning
Nutrient & Targeted Support
- Rooted in internal therapeutic interventions
- Nutrition, supplementation & evidence-informed care EVIDENCE-BASED
- Optional dermal integration where clinically relevant INTEGRATION
Treatment Scope
Case-Specific Interventions are designed to address a defined primary concern within a structured, short-term care window.
- One dominant clinical driver
- Targeted therapeutic intervention
- Measurable progress over a 3–6 week period
Care within this pathway is protocol-driven and time-bound, with structured review points to assess response and determine next steps.
This pathway does not provide:
- Ongoing or open-ended care
- Multi-system or longitudinal case management
- Long-term monitoring beyond the defined intervention window
Where presentations involve overlapping systems, recurrent relapse, or broader clinical complexity, progression into an Advanced Clinical Pathway may be recommended.
Case-Specific Interventions are recommended following clinical assessment to ensure appropriateness, safety, and efficiency of care.
If uncertainty exists regarding suitability, the Initial Clinical Pathway provides the appropriate entry point.